Hiroaki Suefuji

1.3k total citations
44 papers, 946 citations indexed

About

Hiroaki Suefuji is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Hiroaki Suefuji has authored 44 papers receiving a total of 946 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 13 papers in Surgery. Recurrent topics in Hiroaki Suefuji's work include Head and Neck Cancer Studies (12 papers), Salivary Gland Tumors Diagnosis and Treatment (8 papers) and Radiation Therapy and Dosimetry (8 papers). Hiroaki Suefuji is often cited by papers focused on Head and Neck Cancer Studies (12 papers), Salivary Gland Tumors Diagnosis and Treatment (8 papers) and Radiation Therapy and Dosimetry (8 papers). Hiroaki Suefuji collaborates with scholars based in Japan and United States. Hiroaki Suefuji's co-authors include Yoshiyuki Shioyama, Yusuke Demizu, Tomoaki Okimoto, Koichi Ohshima, Tatsuya Ohno, Masashi Koto, Kenji Nemoto, Tadashi Kamada, Kennosuke Karube and Hiroshi Tsuji and has published in prestigious journals such as Journal of Clinical Oncology, Blood and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Hiroaki Suefuji

41 papers receiving 927 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hiroaki Suefuji Japan	20	362	346	253	225	210	44	946
W.F. Mourad United States	18	419 1.2×	300 0.9×	361 1.4×	197 0.9×	65 0.3×	81	985
N.M. Woody United States	21	251 0.7×	611 1.8×	382 1.5×	279 1.2×	107 0.5×	124	1.3k
R Chin United States	12	314 0.9×	187 0.5×	180 0.7×	147 0.7×	47 0.2×	40	679
Kristin Lang Germany	17	330 0.9×	427 1.2×	331 1.3×	171 0.8×	28 0.1×	88	917
Paul Richman United Kingdom	14	383 1.1×	199 0.6×	175 0.7×	129 0.6×	68 0.3×	22	976
Taek‐Keun Nam South Korea	21	715 2.0×	421 1.2×	657 2.6×	42 0.2×	169 0.8×	101	1.5k
Zoltán Takácsi‐Nagy Hungary	19	332 0.9×	219 0.6×	518 2.0×	209 0.9×	483 2.3×	75	1.4k
Damon Choy China	20	640 1.8×	385 1.1×	639 2.5×	886 3.9×	134 0.6×	35	1.3k
E. A. van Slooten Netherlands	10	804 2.2×	299 0.9×	348 1.4×	324 1.4×	163 0.8×	16	1.2k
D.A. Clump United States	19	460 1.3×	413 1.2×	306 1.2×	367 1.6×	33 0.2×	47	1.1k

Countries citing papers authored by Hiroaki Suefuji

Since Specialization

Citations

This map shows the geographic impact of Hiroaki Suefuji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Suefuji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Suefuji more than expected).

Fields of papers citing papers by Hiroaki Suefuji

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Suefuji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Suefuji. The network helps show where Hiroaki Suefuji may publish in the future.

Co-authorship network of co-authors of Hiroaki Suefuji

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Suefuji. A scholar is included among the top collaborators of Hiroaki Suefuji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Suefuji. Hiroaki Suefuji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kubo, Nobuteru, Hiroaki Suefuji, Mio Nakajima, et al.. (2023). Clinical results of carbon ion radiotherapy for inoperable stage I non-small cell lung cancer: A Japanese national registry study (J-CROS-LUNG). Radiotherapy and Oncology. 183. 109640–109640. 10 indexed citations

Kubo, Nobuteru, Hiroaki Suefuji, Mio Nakajima, et al.. (2023). Five-Year Survival Outcomes After Carbon-Ion Radiotherapy for Operable Stage I NSCLC: A Japanese National Registry Study (J-CROS-LUNG). Journal of Thoracic Oncology. 19(3). 491–499. 4 indexed citations

Ogo, Etsuyo, Hiroaki Suefuji, Toshi Abe, et al.. (2021). Analysis of radioactive implant migration in patients treated with iodine-125 seeds for permanent prostate brachytherapy with MRI-classified median lobe hyperplasia. Journal of Contemporary Brachytherapy. 13(3). 254–262. 2 indexed citations

Shinoto, Makoto, Kotaro Terashima, Hiroaki Suefuji, et al.. (2018). A single institutional experience of combined carbon-ion radiotherapy and chemotherapy for unresectable locally advanced pancreatic cancer. Radiotherapy and Oncology. 129(2). 333–339. 44 indexed citations

Toyama, Shingo, Yoshiyuki Shioyama, Hiroaki Suefuji, et al.. (2018). A case of the cirrhotic patient performed living donor liver transplantation after carbon-ion radiotherapy for hepatocellular carcinoma. International Cancer Conference Journal. 7(2). 65–70. 2 indexed citations

Suefuji, Hiroaki, Masashi Koto, Yusuke Demizu, et al.. (2018). A Retrospective Multicenter Study of Carbon Ion Radiotherapy for Locally Advanced Olfactory Neuroblastomas. Anticancer Research. 38(3). 1665–1670. 26 indexed citations

Koto, Masashi, Yusuke Demizu, Jun‐ichi Saitoh, et al.. (2018). Definitive Carbon-Ion Radiation Therapy for Locally Advanced Sinonasal Malignant Tumors: Subgroup Analysis of a Multicenter Study by the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS). International Journal of Radiation Oncology*Biology*Physics. 102(2). 353–361. 45 indexed citations

Hayashi, Kazuhiko, Masashi Koto, Yusuke Demizu, et al.. (2018). A retrospective multicenter study of carbon‐ion radiotherapy for major salivary gland carcinomas: Subanalysis of J‐CROS 1402 HN. Cancer Science. 109(5). 1576–1582. 27 indexed citations

Suefuji, Hiroaki, Etsuyo Ogo, Hiroshi Eto, et al.. (2017). PV-0190: The analysis of prostate cancer with median lobe hyperplasia treated I-125 brachytherapy. Radiotherapy and Oncology. 123. S97–S98.

10.

Sulaiman, Nor Shazrina, Yusuke Demizu, Masashi Koto, et al.. (2017). Multicenter Study of Carbon-Ion Radiation Therapy for Adenoid Cystic Carcinoma of the Head and Neck: Subanalysis of the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS) Study (1402 HN). International Journal of Radiation Oncology*Biology*Physics. 100(3). 639–646. 81 indexed citations

11.

Shinoto, Makoto, Yoshiyuki Shioyama, Akira Matsunobu, et al.. (2016). Dosimetric analysis of upper gastrointestinal ulcer after carbon-ion radiotherapy for pancreatic cancer. Radiotherapy and Oncology. 120(1). 140–144. 27 indexed citations

12.

Shioyama, Yoshiyuki, Hiroshi Tsuji, Hiroaki Suefuji, et al.. (2014). Particle radiotherapy for prostate cancer. International Journal of Urology. 22(1). 33–39. 23 indexed citations

13.

Suefuji, Hiroaki, Hayato Kaida, Masanobu Hayakawa, et al.. (2013). Relationship between 2-deoxy-2-[¹⁸F]-fluoro-d-glucose uptake and clinicopathological factors in patients with diffuse large B-cell lymphoma. Leukemia & lymphoma. 55(3). 520–525. 13 indexed citations

14.

Watanabe, Yuko, Hiroaki Suefuji, Hayato Kaida, et al.. (2012). 18F-FDG uptake in primary gastric malignant lymphoma correlates with glucose transporter 1 expression and histologic malignant potential. International Journal of Hematology. 97(1). 43–49. 27 indexed citations

15.

Suefuji, Hiroaki, et al.. (2012). Automated estimation of number of implanted iodine-125 seeds for prostate brachytherapy based on two-view analysis of pelvic radiographs. Journal of Radiation Research. 53(5). 742–752. 2 indexed citations

16.

Ogo, Etsuyo, Ritsuko Komaki, Toshi Abe, et al.. (2010). The clinical characteristics and non-steroidal treatment for radiation-induced bronchiolitis obliterans organizing pneumonia syndrome after breast-conserving therapy. Radiotherapy and Oncology. 97(1). 95–100. 24 indexed citations

17.

Yoshimura, Junko, Seiya Kato, Kiyoshi Tamaki, et al.. (2007). Mesangiolytic Glomerulopathy after Radiotherapy and Chemotherapy of Gastric Lymphoma. Internal Medicine. 46(22). 1861–1865. 1 indexed citations

18.

Suefuji, Hiroaki, Koichi Ohshima, Naofumi Hayabuchi, Katsumasa Nakamura, & Masahiro Kikuchi. (2003). HTLV‐1 carriers with B‐cell lymphoma of localized stage head and neck: prognosis, clinical and immunopathological features. British Journal of Haematology. 123(4). 606–612. 16 indexed citations

19.

Karube, Kennosuke, Koichi Ohshima, Takeshi Tsuchiya, et al.. (2003). Non-B, Non-T Neoplasms With Lymphoblast Morphology. The American Journal of Surgical Pathology. 27(10). 1366–1374. 30 indexed citations

20.

Ohshima, Koichi, Hiroaki Suefuji, Kennosuke Karube, et al.. (2002). Expression of Chemokine Receptor CXCR3 and its Ligand, Mig, in Gastric and Thyroid Marginal Zone Lymphomas. Possible Migration and Autocrine Mechanism. Leukemia & lymphoma. 44(2). 329–336. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact